Esperion Therapeutics | ESPR - Trade Creditors

Stock Price
3.49
Daily Change
0.10 2.80%
Monthly
-1.83%
Yearly
85.37%
Q1 Forecast
2.70

Esperion Therapeutics reported $77.51M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
AbbVie USD 32.25B 1.2B Jun/2025
Alnylam Pharmaceuticals USD 117.59M 15.2M Sep/2025
Alterity Therapeutics Limited AUD 1.27M 1.81M Dec/2024
Amarin USD 36.71M 8M Sep/2025
Amgen USD 20.89B 1.25B Dec/2025
Biogen USD 432M 18.9M Dec/2025
BioMarin Pharmaceutical USD 798.44M 114.19M Sep/2025
Cipla INR 30.35B 1.98B Sep/2025
CSL USD 3.46B 484M Jun/2025
Cytokinetics USD 22.08M 46.46M Sep/2025
Daiichi Sankyo JPY 568.5B 16.84B Dec/2025
Eli Lilly USD 4.26B 186.5M Sep/2025
Esperion Therapeutics USD 77.51M 2.81M Sep/2025
Geron USD 11.11M 2.88M Sep/2025
Grifols EUR 1.04B 183.31M Jun/2025
Halozyme Therapeutics USD 15.36M 3.33M Sep/2025
Heron Therapeutics USD 12.02M 20K Sep/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
Merck USD 4.15B 102M Sep/2025
Minerva Neurosciences USD 945K 48K Sep/2025
Moderna USD 267M 92M Sep/2025
Nektar Therapeutics USD 15.56M 1.28M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
PTC Therapeutics USD 36.62M 169.69M Sep/2025
Puma Biotechnology USD 6.39M 962K Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Sanofi EUR 22.93B 927M Dec/2025
Sarepta Therapeutics USD 94.02M 42.69M Sep/2025
United Therapeutics USD 468M 36M Sep/2025
Vanda Pharmaceuticals USD 39.09M 33.28M Dec/2024